A Phase 2/3 Study of Brepocitinib in Adults With Cutaneous Sarcoidosis

Clinical trial NCT06978725 · RECRUITING

Trial details

NCT number: NCT06978725
Sponsor: Priovant Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cutaneous Sarcoidosis

Start date: 2025-04-09
Primary completion: 2028-12-31
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.